Skin Diseases, Infectious
"Skin Diseases, Infectious" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Skin diseases caused by bacteria, fungi, parasites, or viruses.
| Descriptor ID |
D012874
|
| MeSH Number(s) |
C01.539.800 C17.800.838
|
| Concept/Terms |
Skin Diseases, Infectious- Skin Diseases, Infectious
- Infectious Skin Diseases
- Disease, Infectious Skin
- Diseases, Infectious Skin
- Infectious Skin Disease
- Skin Disease, Infectious
|
Below are MeSH descriptors whose meaning is more general than "Skin Diseases, Infectious".
Below are MeSH descriptors whose meaning is more specific than "Skin Diseases, Infectious".
This graph shows the total number of publications written about "Skin Diseases, Infectious" by people in this website by year, and whether "Skin Diseases, Infectious" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Skin Diseases, Infectious" by people in Profiles.
-
Chronic immunosuppression in the mature patient. Clin Dermatol. 2018 Mar - Apr; 36(2):255-263.
-
Intestinal infection associated with future onset of an anxiety disorder: Results of a nationally representative study. Brain Behav Immun. 2016 Oct; 57:222-226.
-
The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV: insights from a causal diagram and simulation study. Epidemiol Infect. 2016 10; 144(13):2889-98.
-
Socio-economic profile of patients with community-acquired skin and soft tissue infections in Delhi. Pathog Glob Health. 2014 Sep; 108(6):279-82.
-
Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis. J Eur Acad Dermatol Venereol. 2013 Oct; 27(10):1252-61.
-
EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010 Mar; 34(3):405-17.
-
Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy. J Natl Cancer Inst. 2010 Jan 06; 102(1):47-53.
-
Imported tropical diseases. Dermatol Ther. 2009 Nov-Dec; 22(6):538-49.
-
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. J Clin Oncol. 2001 Aug 15; 19(16):3611-21.
-
Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis. 1992 Mar; 165(3):450-5.